Swiss National Bank’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-104,200
| Closed | -$2.81M | – | 2692 |
|
|
2022
Q4 | $2.81M | Buy |
104,200
+2,500
| +2% | +$67.4K | ﹤0.01% | 1669 |
|
|
2022
Q3 | $1.83M | Buy |
101,700
+2,100
| +2% | +$37.7K | ﹤0.01% | 1936 |
|
|
2022
Q2 | $1.24M | Buy |
99,600
+11,400
| +13% | +$142K | ﹤0.01% | 2243 |
|
|
2022
Q1 | $1.18M | Buy |
88,200
+7,300
| +9% | +$97.3K | ﹤0.01% | 2329 |
|
|
2021
Q4 | $1.26M | Hold |
80,900
| – | – | ﹤0.01% | 2339 |
|
|
2021
Q3 | $1.82M | Buy |
80,900
+800
| +1% | +$17.9K | ﹤0.01% | 2119 |
|
|
2021
Q2 | $1.82M | Sell |
80,100
-2,700
| -3% | -$61.5K | ﹤0.01% | 2171 |
|
|
2021
Q1 | $1.7M | Buy |
82,800
+1,300
| +2% | +$26.8K | ﹤0.01% | 2098 |
|
|
2020
Q4 | $2.25M | Hold |
81,500
| – | – | ﹤0.01% | 1829 |
|
|
2020
Q3 | $1.15M | Buy |
81,500
+1,300
| +2% | +$18.3K | ﹤0.01% | 2013 |
|
|
2020
Q2 | $1.65M | Buy |
80,200
+2,000
| +3% | +$41.2K | ﹤0.01% | 1819 |
|
|
2020
Q1 | $590K | Buy |
78,200
+1,100
| +1% | +$8.3K | ﹤0.01% | 2109 |
|
|
2019
Q4 | $1.2M | Buy |
77,100
+4,100
| +6% | +$63.7K | ﹤0.01% | 2035 |
|
|
2019
Q3 | $380K | Hold |
73,000
| – | – | ﹤0.01% | 2422 |
|
|
2019
Q2 | $661K | Buy |
73,000
+41,800
| +134% | +$378K | ﹤0.01% | 2325 |
|
|
2019
Q1 | $745K | Buy |
31,200
+1,000
| +3% | +$23.9K | ﹤0.01% | 2227 |
|
|
2018
Q4 | $496K | Buy |
30,200
+1,900
| +7% | +$31.2K | ﹤0.01% | 2359 |
|
|
2018
Q3 | $751K | Hold |
28,300
| – | – | ﹤0.01% | 2285 |
|
|
2018
Q2 | $647K | Hold |
28,300
| – | – | ﹤0.01% | 2376 |
|
|
2018
Q1 | $602K | Buy |
28,300
+3,200
| +13% | +$68.1K | ﹤0.01% | 2317 |
|
|
2017
Q4 | $317K | Hold |
25,100
| – | – | ﹤0.01% | 2484 |
|
|
2017
Q3 | $388K | Hold |
25,100
| – | – | ﹤0.01% | 2438 |
|
|
2017
Q2 | $294K | Buy |
+25,100
| New | +$294K | ﹤0.01% | 2521 |
|